Testing effectiveness (Phase 2)Ended earlyNCT04592341
What this trial is testing
Evaluate the Pharmacodynamic (PD) Effects of Once Weekly Administration of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
Who this might be right for
Alzheimer Disease
Hoffmann-La Roche 192